Celator Pharmaceuticals, a pharmaceutical company developing therapies to treat cancer, has received US patent titled, ‘Lipid Carrier Compositions with Enhanced Blood Stability’ from the US Patent and Trademark Office on 27 ...
Clinical-stage biopharmaceutical company Pharmacyclics' new drug application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, has been accepted by the US FDA for two B-cell malignancy indications. ...
Tags: Solvay Group, Medicine
Clinical-stage company OncoMed Pharmaceuticals has announced the issuance of US patent for methods of treating cancer with its antibody vantictumab (OMP-18R5) through 2029. Targeting and inhibiting the Wnt pathway, Vantictumab was ...
Tags: Vantictumab, OncoMed
Clinical-stage pharmaceutical company Adynxx has obtained the US Food and Drug Administration (FDA) fast track designation for its AYX1 injection, which is used for prevention of chronic pain. In a five-cohort, dose-escalating study ...
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
Clinical-stage pharmaceutical company Cempra has received a notification of patent allowance from the US Patent and Trademark Office (USPTO) for taksta loading dose formulation. With the possibility for extension, the patent entitled ...
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax. The patent claims describe methods of preparing an immunologically-active adjuvant-bound, thermostable, ...
Tags: Thermovax Technology, US Patent
Cempra, a clinical-stage pharmaceutical company, has signed an exclusive license and development agreement for solithromycin with Toyama Chemical, a subsidiary of Fujifilm Holdings in Japan. As per the terms of the license and development ...
Tags: Cempra, Toyama Chemical, pharmaceutical
Neuroscience biotech company Cerecor has acquired exclusive, worldwide rights to develop and commercialize MK-0657 from Merck, referred to MSD outside the US and Canada. The small molecule NMDA receptor subunit 2B antagonist MK-0657 will ...
Tags: Cerecor, Global Development Rights, MK-0657
US-based biotechnology firm DART Therapeutics is developing a selective androgen receptor modulator (SARM) drug candidate for Duchenne muscular dystrophy (DMD). DMD is a pediatric rare disease that affects approximately one in 3,600 boys ...
Clinical-stage medical technology company Baronova has secured $27.3m from Series C financing round. The financing, which is led by investments from Sante Ventures and Boston Scientific, will be used by the company to fund a pivotal study ...
Tags: medical technology, weight loss technology, outpatient procedure
Clinical stage biopharmaceutical company Apogenix's Apocept (APG101) has won FDA orphan drug designation to treat myelodysplastic syndromes (MDS). Apogenix also announced the commencement of Apocept Phase I trial in MDS patients in ...
Tags: FDA, orphan drug, biopharmaceutical
Karolinska Development has said that a syndicate led by Rosetta Capital will acquire a minority share in Karolinska's holdings in 13 of its 25 portfolio companies for SEK 220m($33.5m). As part of the transaction, the company will transfer ...
Tags: Karolinska Development, transaction, portfolio company, technology assets
Clinical stage biotechnology company Aphios has obtained notification of allowance(NOA)from the US Patent and Trademark Office(USPTO)for its patent application for oral delivery of insulin. The patent entitled'Polymer ...
Tags: Aphios, USPTO, oral delivery of insulin, NOA